
184.62 Delayed Data As of Dec 08 | ![]() Today’s Change | 140.76 Today|||52-Week Range 194.99 | +25.98% Year-to-Date |
GRFS vs. ZTS: Which Stock Is the Better Value Option? Dec 07 / Zacks.com - Paid Partner Content |
Previous close | 181.83 |
Today’s open | 181.83 |
Day’s range | 181.48 - 184.84 |
Volume | 1,474,667 |
Average volume (3 months) | 1,786,733 |
Market cap | $82.2B |
Earnings growth (last year) | +4.99% |
Earnings growth (this year) | +10.70% |
Earnings growth (next 5 years) | +10.91% |
Revenue growth (last year) | +3.91% |
P/E ratio | 37.6 |
Price/Sales | 8.53 |
Price/Book | 20.41 |
Today’s change | Today’s % change | |
---|---|---|
VRTXVertex Pharmaceutica... | -3.92 | -1.11% |
REGNRegeneron Pharmaceut... | -9.16 | -1.08% |
---- | ||
GSKGlaxoSmithKline | -0.05 | -0.14% |
Next reporting date | February 15, 2024 |
EPS forecast (this quarter) | $1.40 |
Annual revenue (last year) | $8.1B |
Annual profit (last year) | $2.1B |
Net profit margin | 26.16% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Parsippany, New Jersey |